Diversified Healthcare Trust (DHC) Financials

$3.14 +0.13 (+4.32%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$3.25 +0.11 (+3.47%)

As of 05/23/2025 07:55 PM Eastern

Annual Income Statements for Diversified Healthcare Trust

This table shows Diversified Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-370	-294	-16
Consolidated Net Income / (Loss)	-370	-294	-16
Net Income / (Loss) Continuing Operations	-370	-294	-16
Total Pre-Tax Income	-371	-273	-21
Total Operating Income	-126	-103	-94
Total Gross Profit	1,495	1,410	1,284
Total Revenue	1,495	1,410	1,284
Operating Revenue	1,495	1,410	1,284
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	1,621	1,514	1,377
Selling, General & Admin Expense	1,263	1,200	1,136
Depreciation Expense	285	284	239
Impairment Charge	71	18	0.00
Restructuring Charge	2.51	11	2.61
Total Other Income / (Expense), net	-246	-169	73
Interest Expense	236	194	239
Interest & Investment Income	8.95	24	16
Other Income / (Expense), net	-19	1.21	296
Income Tax Expense	0.47	0.45	0.71
Other Gains / (Losses), net	1.60	-20	6.06
Basic Earnings per Share	($1.55)	($1.23)	($0.07)
Weighted Average Basic Shares Outstanding	239.54M	238.84M	238.31M
Diluted Earnings per Share	($1.55)	($1.23)	($0.07)
Weighted Average Diluted Shares Outstanding	239.54M	238.84M	238.31M
Weighted Average Basic & Diluted Shares Outstanding	241.27M	240.42M	239.68M
Cash Dividends to Common per Share	$0.04	$0.04	$0.04

This table shows Diversified Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-8.99	-87	-99	-98	-86	-103	-66	-73	-53	-65	-81
Consolidated Net Income / (Loss)	-8.99	-87	-99	-98	-86	-103	-66	-73	-53	-65	-81
Net Income / (Loss) Continuing Operations	-8.99	-87	-99	-98	-86	-103	-66	-73	-53	-65	-81
Total Pre-Tax Income	-10	-99	-99	-85	-88	-80	-65	-75	-52	-63	-84
Total Operating Income	-36	-41	-42	-16	-27	-33	-21	-33	-17	-18	-33
Total Gross Profit	387	380	374	371	371	362	357	346	346	337	323
Total Revenue	387	380	374	371	371	362	357	346	346	337	323
Operating Revenue	387	380	374	371	371	362	357	346	346	337	323
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Operating Expenses	423	421	416	387	398	394	377	379	363	355	356
Selling, General & Admin Expense	323	314	324	310	315	309	305	294	292	291	295
Depreciation Expense	68	78	69	68	70	84	67	68	65	63	60
Impairment Charge	38	29	23	6.55	12	-	1.16	11	5.93	-	0.00
Restructuring Charge	0.02	0.27	0.33	1.83	0.09	1.04	3.68	6.04	0.09	0.78	0.29
Other Special Charges / (Income)	-7.52	-	-	-	-	-	-	-	-	-	-
Total Other Income / (Expense), net	25	-58	-57	-70	-61	-47	-45	-42	-35	-45	-51
Interest Expense	87	60	59	59	58	50	48	47	49	49	47
Interest & Investment Income	2.10	1.74	2.58	2.40	2.24	2.96	3.24	5.13	12	22	1.43
Other Income / (Expense), net	110	0.04	0.11	-13	-5.87	-0.03	0.00	0.00	1.23	-17	-5.04
Income Tax Expense	0.05	-0.04	0.15	0.17	0.19	0.07	0.19	0.22	-0.03	-0.14	0.01
Other Gains / (Losses), net	1.49	11	0.53	-12	1.90	-23	-0.15	2.93	-0.65	-2.63	2.13
Basic Earnings per Share	($0.04)	($0.37)	($0.41)	($0.41)	($0.36)	($0.43)	($0.28)	($0.30)	($0.22)	($0.28)	($0.34)
Weighted Average Basic Shares Outstanding	239.96M	239.54M	239.67M	239.33M	239.19M	238.84M	238.89M	238.68M	238.59M	238.31M	238.34M
Diluted Earnings per Share	($0.04)	($0.37)	($0.41)	($0.41)	($0.36)	($0.43)	($0.28)	($0.30)	($0.22)	($0.28)	($0.34)
Weighted Average Diluted Shares Outstanding	239.96M	239.54M	239.67M	239.33M	239.19M	238.84M	238.89M	238.68M	238.59M	238.31M	238.34M
Weighted Average Basic & Diluted Shares Outstanding	241.25M	241.27M	241.28M	240.57M	240.39M	240.42M	240.45M	239.79M	239.68M	239.68M	239.70M
Cash Dividends to Common per Share	$0.01	-	$0.01	-	-	-	-	-	-	-	-

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-97	-441	-329
Net Cash From Operating Activities	112	10	-40
Net Cash From Continuing Operating Activities	112	10	-40
Net Income / (Loss) Continuing Operations	-370	-294	-16
Consolidated Net Income / (Loss)	-370	-294	-16
Depreciation Expense	285	284	239
Amortization Expense	104	12	8.90
Non-Cash Adjustments To Reconcile Net Income	87	36	-274
Changes in Operating Assets and Liabilities, net	6.82	-28	1.64
Net Cash From Investing Activities	-187	-202	388
Net Cash From Continuing Investing Activities	-187	-202	388
Purchase of Property, Plant & Equipment	-202	-235	-299
Acquisitions	-21	0.00	-75
Sale of Property, Plant & Equipment	34	18	0.82
Divestitures	0.00	0.00	108
Sale and/or Maturity of Investments	0.00	0.00	638
Other Investing Activities, net	1.70	15	14
Net Cash From Financing Activities	-22	-250	-676
Net Cash From Continuing Financing Activities	-22	-250	-676
Repayment of Debt	-132	-990	-666
Repurchase of Common Equity	-0.90	-0.39	-0.17
Payment of Dividends	-9.63	-9.60	-9.57
Issuance of Debt	120	750	0.00

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	157	-112	-8.69	62	-39	-32	-78	-26	-306	-113	-68
Net Cash From Operating Activities	-3.24	18	21	44	29	-7.21	-14	26	6.04	-3.41	-5.09
Net Cash From Continuing Operating Activities	-3.24	18	21	44	29	-7.21	-14	26	6.04	-3.41	-5.09
Net Income / (Loss) Continuing Operations	-8.99	-87	-99	-98	-86	-103	-66	-73	-53	-65	-81
Consolidated Net Income / (Loss)	-8.99	-87	-99	-98	-86	-103	-66	-73	-53	-65	-81
Depreciation Expense	68	78	69	68	70	84	67	68	65	63	60
Amortization Expense	26	27	26	26	25	5.22	2.32	2.27	1.76	2.00	1.95
Non-Cash Adjustments To Reconcile Net Income	-87	17	22	32	17	24	1.58	14	-3.42	6.09	4.12
Changes in Operating Assets and Liabilities, net	-1.58	-16	2.93	17	3.16	-18	-19	14	-4.44	-9.53	9.92
Net Cash From Investing Activities	291	-66	-25	-37	-59	-51	-60	-34	-57	-96	-44
Net Cash From Continuing Investing Activities	291	-66	-25	-37	-59	-51	-60	-34	-57	-96	-44
Purchase of Property, Plant & Equipment	-40	-67	-47	-41	-47	-67	-60	-48	-60	-110	-72
Acquisitions	-5.80	-5.72	-	-	-15	-	-	-	0.00	-	-
Sale of Property, Plant & Equipment	318	6.32	21	3.98	3.34	15	-	-	3.55	-	0.03
Sale and/or Maturity of Investments	17	-	-	-	-	-	-	-	-	-	-
Other Investing Activities, net	1.31	-	1.53	-	-	0.53	-	-	-	14	-
Net Cash From Financing Activities	-131	-64	-4.63	54	-8.56	26	-3.48	-18	-255	-13	-19
Net Cash From Continuing Financing Activities	-131	-64	-4.63	54	-8.56	26	-3.48	-18	-255	-13	-19
Repayment of Debt	-269	-61	-1.44	-63	-6.08	-721	-0.73	-15	-253	-11	-16
Repurchase of Common Equity	-0.01	-0.00	-0.78	-0.04	-0.08	-0.01	-0.35	-0.03	-0.01	-0.01	-0.16
Payment of Dividends	-2.41	-2.41	-2.41	-2.40	-2.40	-2.40	-2.40	-2.40	-2.40	-2.40	-2.39
Issuance of Debt	140	-	-	-	-	750	-	-	-	-	-

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	5,137	5,446	6,002
Total Current Assets	149	253	667
Cash & Equivalents	145	246	658
Accounts Receivable	4.06	6.08	8.72
Plant, Property, & Equipment, net	4,340	4,798	4,864
Plant, Property & Equipment, gross	6,423	6,818	6,693
Accumulated Depreciation	2,083	2,021	1,828
Total Noncurrent Assets	648	395	471
Long-Term Investments	151	130	161
Intangible Assets	26	34	45
Other Noncurrent Operating Assets	470	232	264
Total Liabilities & Shareholders' Equity	5,137	5,446	6,002
Total Liabilities	3,178	3,109	3,363
Total Current Liabilities	0.00	0.03	0.00
Total Noncurrent Liabilities	3,178	3,089	3,363
Long-Term Debt	2,784	2,804	3,018
Other Noncurrent Operating Liabilities	388	285	346
Other Noncurrent Nonoperating Liabilities	6.02	-	0.00
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,959	2,337	2,639
Total Preferred & Common Equity	1,959	2,337	2,639
Total Common Equity	1,959	2,337	2,639
Common Stock	4,623	4,621	4,619
Retained Earnings	1,408	1,778	2,072
Accumulated Other Comprehensive Income / (Loss)	-0.02	0.00	-
Other Equity Adjustments	-4,072	-4,062	-4,053

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	4,996	5,285	5,333	5,348	5,530	5,585	5,667	6,072
Total Current Assets	303	257	266	208	279	357	383	801
Cash & Equivalents	303	257	266	207	278	338	380	691
Plant, Property, & Equipment, net	4,255	4,562	4,655	4,709	4,801	4,804	4,845	4,812
Plant, Property & Equipment, gross	6,367	6,673	6,762	6,771	6,767	6,712	6,724	6,597
Accumulated Depreciation	2,112	2,111	2,107	2,062	1,966	1,908	1,879	1,785
Total Noncurrent Assets	438	467	413	431	450	425	439	460
Long-Term Investments	142	134	134	146	154	155	153	159
Intangible Assets	24	28	30	32	37	39	42	48
Other Noncurrent Operating Assets	272	305	250	253	260	230	244	252
Total Liabilities & Shareholders' Equity	4,996	5,285	5,333	5,348	5,530	5,585	5,667	6,072
Total Liabilities	3,048	3,237	3,184	3,099	3,089	3,076	3,083	3,366
Total Current Liabilities	0.00	0.00	0.00	0.22	450	450	450	700
Total Noncurrent Liabilities	3,048	3,237	3,184	3,087	2,638	2,626	2,633	2,666
Long-Term Debt	2,800	2,945	2,920	2,826	2,335	2,335	2,348	2,357
Other Noncurrent Operating Liabilities	242	289	264	261	303	291	284	308
Other Noncurrent Nonoperating Liabilities	5.57	2.62	0.58	-	-	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,948	2,048	2,149	2,249	2,442	2,509	2,584	2,706
Total Preferred & Common Equity	1,948	2,048	2,149	2,249	2,442	2,509	2,584	2,706
Total Common Equity	1,948	2,048	2,149	2,249	2,442	2,509	2,584	2,706
Common Stock	4,623	4,622	4,622	4,621	4,621	4,620	4,620	4,619
Retained Earnings	1,399	1,495	1,594	1,692	1,881	1,947	2,019	2,137
Accumulated Other Comprehensive Income / (Loss)	0.00	0.01	-0.03	-0.00	-	-	-	-
Other Equity Adjustments	-4,074	-4,069	-4,067	-4,065	-4,060	-4,057	-4,055	-4,050

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	6.04%	9.87%	-7.20%
EBITDA Growth	25.91%	-57.04%	-71.86%
EBIT Growth	-41.82%	-150.44%	-56.11%
NOPAT Growth	-21.83%	-10.09%	-177.62%
Net Income Growth	-26.12%	-1,761.11%	-108.77%
EPS Growth	-26.02%	-1,657.14%	-109.59%
Operating Cash Flow Growth	970.52%	125.98%	36.27%
Free Cash Flow Firm Growth	1,353.20%	-111.21%	-81.19%
Invested Capital Growth	-6.92%	-1.09%	-4.70%
Revenue Q/Q Growth	1.22%	1.78%	0.01%
EBITDA Q/Q Growth	2.96%	15.78%	244.82%
EBIT Q/Q Growth	-6.20%	2.73%	265.16%
NOPAT Q/Q Growth	-7.26%	-16.22%	46.24%
Net Income Q/Q Growth	3.92%	-14.53%	-103.79%
EPS Q/Q Growth	3.73%	-13.89%	-104.02%
Operating Cash Flow Q/Q Growth	29.26%	-26.63%	53.66%
Free Cash Flow Firm Q/Q Growth	128.05%	62.67%	-83.18%
Invested Capital Q/Q Growth	-3.31%	-0.21%	1.47%
Profitability Metrics	-	-	-
Gross Margin	100.00%	100.00%	200.00%
EBITDA Margin	16.30%	13.73%	35.10%
Operating Margin	-8.41%	-7.32%	10.46%
EBIT Margin	-9.68%	-7.24%	33.53%
Profit (Net Income) Margin	-24.76%	-20.82%	-1.23%
Tax Burden Percent	99.70%	107.67%	74.69%
Interest Burden Percent	256.53%	267.10%	-19.70%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.91%	-1.50%	-1.33%
ROIC Less NNEP Spread (ROIC-NNEP)	-13.33%	-11.03%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-15.33%	-10.30%	0.00%
Return on Equity (ROE)	-17.24%	-11.80%	0.00%
Cash Return on Invested Capital (CROIC)	5.26%	-0.40%	3.49%
Operating Return on Assets (OROA)	-2.74%	-1.78%	3.21%
Return on Assets (ROA)	-7.00%	-5.13%	-0.25%
Return on Common Equity (ROCE)	-17.24%	-11.80%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-18.90%	-12.56%	-0.60%
Net Operating Profit after Tax (NOPAT)	-88	-72	-66
NOPAT Margin	-5.89%	-5.13%	7.32%
Net Nonoperating Expense Percent (NNEP)	11.42%	9.53%	-2.16%
Return On Investment Capital (ROIC_SIMPLE)	-1.86%	-1.41%	-1.16%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	84.46%	85.11%	88.46%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	108.41%	107.32%	214.62%
Earnings before Interest and Taxes (EBIT)	-145	-102	202
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	244	194	451
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.28	0.38	0.06
Price to Tangible Book Value (P/TBV)	0.29	0.38	0.06
Price to Revenue (P/Rev)	0.37	0.63	0.23
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	1.75%	1.09%	13.03%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.68	0.69	0.48
Enterprise Value to Revenue (EV/Rev)	2.03	2.35	1.83
Enterprise Value to EBITDA (EV/EBITDA)	12.48	17.10	10.41
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	11.59
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	27.09	315.72	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	12.53	0.00	27.16
Leverage & Solvency	-	-	-
Debt to Equity	1.42	1.20	0.00
Long-Term Debt to Equity	1.42	1.20	0.00
Financial Leverage	1.15	0.93	0.00
Leverage Ratio	2.46	2.30	0.00
Compound Leverage Factor	6.32	6.15	0.00
Debt to Total Capital	58.70%	54.54%	53.35%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	58.70%	54.54%	53.35%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	41.30%	45.46%	46.65%
Debt to EBITDA	11.42	14.49	6.70
Net Debt to EBITDA	10.21	12.54	9.76
Long-Term Debt to EBITDA	11.42	14.49	13.40
Debt to NOPAT	-31.61	-38.78	-26.85
Net Debt to NOPAT	-28.25	-33.57	-19.66
Long-Term Debt to NOPAT	-31.61	-38.78	-45.95
Altman Z-Score	0.72	0.88	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	0.00	7,907.56	0.00
Quick Ratio	0.00	7,875.63	0.00
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	243	-19	173
Operating Cash Flow to CapEx	66.98%	4.84%	-13.52%
Free Cash Flow to Firm to Interest Expense	1.03	-0.10	2.36
Operating Cash Flow to Interest Expense	0.48	0.05	-0.17
Operating Cash Flow Less CapEx to Interest Expense	-0.23	-1.06	-1.42
Efficiency Ratios	-	-	-
Asset Turnover	0.28	0.25	0.20
Accounts Receivable Turnover	295.01	190.62	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	0.33	0.29	0.26
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	1.24	1.91	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	1.24	1.91	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	4,453	4,784	4,837
Invested Capital Turnover	0.32	0.29	0.26
Increase / (Decrease) in Invested Capital	-331	-53	-238
Enterprise Value (EV)	3,041	3,310	2,346
Market Capitalization	552	883	147
Book Value per Share	$8.12	$9.72	$11.01
Tangible Book Value per Share	$8.01	$9.58	$10.82
Total Capital	4,743	5,141	5,656
Total Debt	2,784	2,804	3,018
Total Long-Term Debt	2,784	2,804	3,018
Net Debt	2,488	2,427	2,198
Capital Expenditures (CapEx)	168	217	299
Debt-free, Cash-free Net Working Capital (DFCFNWC)	4.06	6.05	8.72
Debt-free Net Working Capital (DFNWC)	149	253	667
Net Working Capital (NWC)	149	253	667
Net Nonoperating Expense (NNE)	282	221	-50
Net Nonoperating Obligations (NNO)	2,494	2,447	2,198
Total Depreciation and Amortization (D&A)	389	296	248
Debt-free, Cash-free Net Working Capital to Revenue	0.27%	0.43%	1.36%
Debt-free Net Working Capital to Revenue	9.94%	17.94%	105.57%
Net Working Capital to Revenue	9.94%	17.94%	103.90%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($1.55)	($1.23)	($0.07)
Adjusted Weighted Average Basic Shares Outstanding	239.54M	238.84M	238.31M
Adjusted Diluted Earnings per Share	($1.55)	($1.23)	($0.07)
Adjusted Weighted Average Diluted Shares Outstanding	239.54M	238.84M	238.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	241.27M	240.42M	239.68M
Normalized Net Operating Profit after Tax (NOPAT)	-37	-52	-64
Normalized NOPAT Margin	-2.46%	-3.68%	-9.95%
Pre Tax Income Margin	-24.83%	-19.33%	-3.29%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-0.61	-0.53	0.85
NOPAT to Interest Expense	-0.37	-0.37	0.39
EBIT Less CapEx to Interest Expense	-1.33	-1.64	-0.40
NOPAT Less CapEx to Interest Expense	-1.09	-1.49	-0.85
Payout Ratios	-	-	-
Dividend Payout Ratio	-2.60%	-3.27%	-60.66%
Augmented Payout Ratio	-2.84%	-3.40%	-61.74%

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.34%	5.00%	4.80%	7.27%	7.15%	7.32%	10.41%	10.60%	11.36%	0.05%	-4.30%
EBITDA Growth	170.57%	12.46%	8.95%	73.04%	22.15%	88.34%	100.40%	-7.83%	-85.64%	27.18%	-48.28%
EBIT Growth	327.94%	-25.90%	-101.62%	12.57%	-110.41%	8.08%	45.06%	-66.80%	-105.24%	24.32%	-59.45%
NOPAT Growth	-33.65%	-26.12%	-102.15%	52.58%	-59.83%	-79.29%	36.67%	-72.79%	49.78%	72.83%	-253.98%
Net Income Growth	89.58%	14.74%	-50.03%	-34.85%	-63.81%	-57.01%	19.28%	33.65%	-121.90%	-117.81%	7.40%
EPS Growth	88.89%	13.95%	-46.43%	-36.67%	-63.64%	-53.57%	17.65%	34.78%	-121.78%	-118.30%	10.53%
Operating Cash Flow Growth	-111.34%	352.39%	250.62%	72.47%	373.39%	-111.72%	-175.55%	204.43%	183.18%	93.21%	87.35%
Free Cash Flow Firm Growth	319.15%	902.85%	3,773.50%	224.87%	169.11%	-86.65%	-100.38%	-97.34%	-110.65%	-75.00%	609.33%
Invested Capital Growth	-8.94%	-6.92%	-3.93%	-2.33%	-2.35%	-1.09%	-0.21%	-1.12%	2.66%	-4.70%	-19.30%
Revenue Q/Q Growth	1.91%	1.60%	0.61%	0.17%	2.56%	1.41%	2.98%	0.05%	2.71%	4.32%	3.16%
EBITDA Q/Q Growth	166.86%	19.42%	-18.66%	4.43%	10.87%	15.69%	29.18%	-26.28%	70.94%	1,467.78%	-40.59%
EBIT Q/Q Growth	281.13%	2.69%	-46.14%	11.51%	-0.04%	-55.84%	36.63%	-112.98%	56.30%	919.07%	-92.39%
NOPAT Q/Q Growth	13.00%	2.86%	-170.13%	41.46%	17.90%	-55.71%	36.63%	-97.29%	7.90%	1,063.84%	-72.91%
Net Income Q/Q Growth	89.72%	11.39%	-0.85%	-13.45%	15.90%	-55.92%	9.36%	-37.82%	19.39%	19.84%	25.50%
EPS Q/Q Growth	89.19%	9.76%	0.00%	-13.89%	16.28%	-53.57%	6.67%	-36.36%	21.43%	17.65%	26.09%
Operating Cash Flow Q/Q Growth	-117.82%	-13.91%	-52.28%	54.86%	496.75%	48.62%	-154.64%	325.04%	277.44%	33.13%	79.29%
Free Cash Flow Firm Q/Q Growth	31.72%	90.03%	58.17%	5.87%	215.14%	796.09%	-113.99%	122.52%	-160.86%	-79.96%	-3.21%
Invested Capital Q/Q Growth	-3.22%	-3.31%	-1.39%	-1.31%	-1.07%	-0.21%	0.25%	-1.33%	0.19%	1.47%	-0.65%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	200.00%	100.00%	100.00%
EBITDA Margin	43.64%	16.66%	14.18%	17.54%	16.82%	15.56%	13.64%	10.87%	29.51%	8.87%	7.51%
Operating Margin	-9.24%	-10.83%	-11.32%	-4.22%	-7.22%	-9.01%	-5.87%	-9.54%	-9.32%	-5.40%	-10.24%
EBIT Margin	19.23%	-10.82%	-11.29%	-7.78%	-8.80%	-9.02%	-5.87%	-9.54%	-8.96%	-10.53%	-11.80%
Profit (Net Income) Margin	-2.32%	-23.04%	-26.41%	-26.35%	-23.26%	-28.37%	-18.45%	-20.96%	-15.22%	-19.39%	-25.24%
Tax Burden Percent	86.20%	88.36%	99.62%	114.61%	98.06%	128.37%	100.51%	96.40%	202.37%	0.00%	97.47%
Interest Burden Percent	-14.01%	240.99%	234.76%	295.69%	269.59%	244.96%	312.69%	227.92%	335.58%	177.05%	219.47%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-2.16%	-2.45%	-2.49%	-0.91%	-1.51%	-1.85%	-1.19%	-1.88%	-0.93%	-0.98%	-1.71%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.50%	-4.83%	-5.31%	-4.54%	-4.36%	-5.28%	-3.48%	-4.17%	-2.94%	-3.26%	-3.78%
Return on Net Nonoperating Assets (RNNOA)	-1.73%	-5.55%	-5.80%	-4.67%	-4.28%	-4.93%	-3.01%	-3.40%	-2.19%	-2.84%	-4.17%
Return on Equity (ROE)	-3.90%	-8.01%	-8.29%	-5.58%	-5.80%	-6.78%	-4.20%	-5.27%	-3.12%	-3.81%	-5.88%
Cash Return on Invested Capital (CROIC)	7.27%	5.26%	2.26%	0.94%	0.72%	-0.40%	-1.08%	-0.35%	-3.07%	3.49%	19.10%
Operating Return on Assets (OROA)	5.62%	-3.06%	-3.09%	-2.08%	-2.29%	-2.22%	-1.40%	-2.20%	-0.95%	-2.14%	-2.30%
Return on Assets (ROA)	-0.68%	-6.51%	-7.22%	-7.05%	-6.06%	-6.99%	-4.41%	-4.83%	-3.23%	-3.94%	-4.93%
Return on Common Equity (ROCE)	-3.90%	-8.01%	-8.29%	-5.58%	-5.80%	-6.78%	-4.20%	-5.27%	-3.12%	-3.81%	-5.75%
Return on Equity Simple (ROE_SIMPLE)	-15.04%	0.00%	-18.81%	-16.40%	-14.55%	0.00%	-10.50%	-10.84%	-11.95%	0.00%	15.38%
Net Operating Profit after Tax (NOPAT)	-25	-29	-30	-11	-19	-23	-15	-23	-12	-13	-23
NOPAT Margin	-6.47%	-7.58%	-7.93%	-2.95%	-5.05%	-6.31%	-4.11%	-6.68%	-3.39%	-3.78%	-7.16%
Net Nonoperating Expense Percent (NNEP)	-0.66%	2.37%	2.81%	3.63%	2.85%	3.43%	2.30%	2.29%	2.01%	2.28%	2.07%
Return On Investment Capital (ROIC_SIMPLE)	-0.53%	-0.61%	-0.59%	-0.22%	-0.37%	-0.44%	-0.28%	-0.44%	-0.22%	-0.23%	-0.40%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	83.58%	82.70%	86.62%	83.56%	85.00%	85.59%	85.66%	84.78%	168.74%	86.36%	91.44%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	109.24%	110.83%	111.32%	104.22%	107.22%	109.01%	105.87%	109.54%	209.68%	105.40%	110.24%
Earnings before Interest and Taxes (EBIT)	74	-41	-42	-29	-33	-33	-21	-33	-16	-35	-38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	169	63	53	65	62	56	49	38	51	30	24
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.30	0.28	0.49	0.34	0.26	0.38	0.19	0.21	0.24	0.06	0.08
Price to Tangible Book Value (P/TBV)	0.30	0.29	0.50	0.34	0.26	0.38	0.19	0.21	0.25	0.06	0.08
Price to Revenue (P/Rev)	0.38	0.37	0.68	0.50	0.41	0.63	0.33	0.39	0.24	0.23	0.17
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.54
Dividend Yield	1.67%	1.75%	0.96%	1.33%	1.65%	1.09%	2.11%	1.83%	6.15%	13.03%	4.29%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	186.39%
Enterprise Value to Invested Capital (EV/IC)	0.68	0.68	0.77	0.70	0.65	0.69	0.59	0.58	1.06	0.48	0.48
Enterprise Value to Revenue (EV/Rev)	1.94	2.03	2.41	2.22	2.13	2.35	2.03	2.07	1.95	1.83	1.81
Enterprise Value to EBITDA (EV/EBITDA)	8.37	12.48	15.02	13.97	14.91	17.10	16.79	19.58	17.63	10.41	17.76
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.59	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	36.48	27.09	40.95	62.84	92.43	315.72	196.43	120.42	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	8.93	12.53	33.40	73.27	88.95	0.00	0.00	0.00	0.00	13.58	2.26
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.44	1.42	1.44	1.36	1.26	1.20	1.14	1.11	2.17	1.14	1.13
Long-Term Debt to Equity	1.44	1.42	1.44	1.36	1.26	1.20	0.96	0.93	1.82	1.14	0.87
Financial Leverage	1.15	1.15	1.09	1.03	0.98	0.93	0.86	0.82	1.49	0.87	1.10
Leverage Ratio	2.46	2.46	2.41	2.34	2.28	2.30	2.25	2.21	4.54	2.38	2.57
Compound Leverage Factor	-0.35	5.94	5.65	6.93	6.14	5.64	7.05	5.05	15.23	4.22	5.64
Debt to Total Capital	58.98%	58.70%	58.98%	57.60%	55.68%	54.54%	53.29%	52.60%	103.99%	53.35%	53.06%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.61%	8.50%	16.72%	0.00%	12.14%
Long-Term Debt to Total Capital	58.98%	58.70%	58.98%	57.60%	55.68%	54.54%	44.68%	44.10%	43.63%	53.35%	40.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	41.03%	41.30%	41.02%	42.40%	44.32%	45.46%	46.71%	47.40%	48.01%	46.65%	46.94%
Debt to EBITDA	8.00	11.42	12.44	12.57	13.79	14.49	16.66	19.50	19.17	6.70	23.41
Net Debt to EBITDA	6.73	10.21	10.79	10.85	12.06	12.54	14.07	15.91	15.49	4.88	16.06
Long-Term Debt to EBITDA	8.00	11.42	12.44	12.57	13.79	14.49	13.97	16.35	16.08	6.70	18.05
Debt to NOPAT	-29.67	-31.61	-35.86	-43.48	-35.63	-38.78	-44.76	-39.39	-45.91	-45.95	-25.04
Net Debt to NOPAT	-24.96	-28.25	-31.11	-37.53	-31.16	-33.57	-37.81	-32.14	-37.11	-33.47	-17.18
Long-Term Debt to NOPAT	-29.67	-31.61	-35.86	-43.48	-35.63	-38.78	-37.53	-33.02	-38.53	-45.95	-19.31
Altman Z-Score	0.93	0.79	0.89	0.87	0.85	0.92	0.77	0.79	0.77	0.84	0.74
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.17%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.00	0.00	0.00	954.88	7,907.56	0.62	0.79	0.85	0.00	1.14
Quick Ratio	0.00	0.00	0.00	0.00	950.11	7,875.63	0.62	0.75	1.69	0.00	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	398	302	159	100	95	30	-4.33	31	-137	226	1,126
Operating Cash Flow to CapEx	0.00%	30.12%	79.10%	119.64%	65.93%	-13.92%	-23.20%	53.90%	10.65%	-3.09%	-7.03%
Free Cash Flow to Firm to Interest Expense	4.58	5.07	2.67	1.71	1.65	0.60	-0.09	0.65	-2.81	4.57	23.99
Operating Cash Flow to Interest Expense	-0.04	0.31	0.36	0.75	0.50	-0.14	-0.29	0.54	0.12	-0.07	-0.11
Operating Cash Flow Less CapEx to Interest Expense	3.17	-0.71	-0.09	0.12	-0.26	-1.17	-1.56	-0.46	-1.04	-2.30	-1.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.29	0.28	0.27	0.27	0.26	0.25	0.24	0.23	0.21	0.20	0.20
Accounts Receivable Turnover	0.00	295.01	0.00	0.00	0.00	190.62	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.34	0.33	0.32	0.31	0.30	0.29	0.29	0.28	0.28	0.26	0.24
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	1.24	0.00	0.00	0.00	1.91	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	1.24	0.00	0.00	0.00	1.91	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,310	4,453	4,606	4,671	4,733	4,784	4,794	4,782	4,846	4,837	4,804
Invested Capital Turnover	0.33	0.32	0.31	0.31	0.30	0.29	0.29	0.28	0.28	0.26	0.24
Increase / (Decrease) in Invested Capital	-423	-331	-189	-111	-114	-53	-10	-54	126	-238	-1,149
Enterprise Value (EV)	2,933	3,041	3,555	3,246	3,054	3,310	2,806	2,797	2,574	4,700	2,321
Market Capitalization	576	552	1,000	725	583	883	454	525	630	147	223
Book Value per Share	$8.07	$8.12	$8.51	$8.94	$9.40	$9.72	$10.18	$10.47	$10.78	$11.01	$11.32
Tangible Book Value per Share	$7.97	$8.01	$8.40	$8.82	$9.27	$9.58	$10.03	$10.31	$10.60	$10.82	$11.11
Total Capital	4,748	4,743	4,994	5,069	5,074	5,141	5,227	5,294	5,382	5,656	5,765
Total Debt	2,800	2,784	2,945	2,920	2,826	2,804	2,785	2,785	2,798	3,018	3,059
Total Long-Term Debt	2,800	2,784	2,945	2,920	2,826	2,804	2,335	2,335	2,348	3,018	2,359
Net Debt	2,356	2,488	2,554	2,521	2,471	2,427	2,352	2,272	2,262	2,198	2,098
Capital Expenditures (CapEx)	-279	60	27	37	43	52	60	48	57	110	72
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	4.06	0.00	0.00	-0.22	6.05	-0.43	-0.31	0.00	8.72	0.00
Debt-free Net Working Capital (DFNWC)	303	149	257	266	208	253	279	357	383	667	801
Net Working Capital (NWC)	303	149	257	266	208	253	-171	-93	-67	667	101
Net Nonoperating Expense (NNE)	-16	59	69	87	68	80	51	49	41	53	58
Net Nonoperating Obligations (NNO)	2,362	2,494	2,557	2,521	2,484	2,447	2,353	2,273	2,262	2,198	2,098
Total Depreciation and Amortization (D&A)	94	104	95	94	95	89	70	71	67	65	62
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.27%	0.00%	0.00%	-0.02%	0.43%	-0.03%	-0.02%	0.00%	0.68%	0.00%
Debt-free Net Working Capital to Revenue	20.02%	9.94%	17.36%	18.19%	14.49%	17.94%	20.11%	26.39%	29.02%	51.95%	62.40%
Net Working Capital to Revenue	20.02%	9.94%	17.36%	18.19%	14.49%	17.94%	-12.36%	-6.89%	-5.11%	103.90%	7.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.04)	($0.37)	($0.41)	($0.41)	($0.36)	($0.43)	($0.28)	($0.30)	($0.22)	($0.28)	($0.34)
Adjusted Weighted Average Basic Shares Outstanding	239.96M	239.54M	239.67M	239.33M	239.19M	238.84M	238.89M	238.68M	238.59M	238.31M	238.34M
Adjusted Diluted Earnings per Share	($0.04)	($0.37)	($0.41)	($0.41)	($0.36)	($0.43)	($0.28)	($0.30)	($0.22)	($0.28)	($0.34)
Adjusted Weighted Average Diluted Shares Outstanding	239.96M	239.54M	239.67M	239.33M	239.19M	238.84M	238.89M	238.68M	238.59M	238.31M	238.34M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	241.25M	241.27M	241.28M	240.57M	240.39M	240.42M	240.45M	239.79M	239.68M	239.68M	239.70M
Normalized Net Operating Profit after Tax (NOPAT)	-3.35	-8.27	-13	-5.10	-10	-22	-11	-11	-7.51	-12	-23
Normalized NOPAT Margin	-0.87%	-2.18%	-3.55%	-1.37%	-2.74%	-6.11%	-3.16%	-3.17%	-2.17%	-3.62%	-7.10%
Pre Tax Income Margin	-2.69%	-26.07%	-26.51%	-22.99%	-23.73%	-22.10%	-18.36%	-21.74%	-30.08%	-18.65%	-25.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.86	-0.69	-0.71	-0.49	-0.57	-0.65	-0.44	-0.70	-0.63	-0.72	-0.81
NOPAT to Interest Expense	-0.29	-0.48	-0.50	-0.19	-0.33	-0.45	-0.31	-0.49	-0.46	-0.26	-0.49
EBIT Less CapEx to Interest Expense	4.06	-1.70	-1.16	-1.12	-1.32	-1.68	-1.70	-1.70	-1.80	-2.95	-2.36
NOPAT Less CapEx to Interest Expense	2.92	-1.50	-0.95	-0.81	-1.08	-1.48	-1.57	-1.49	-1.62	-2.49	-2.04
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-3.29%	-2.60%	-2.50%	-2.73%	-2.93%	-3.27%	-3.74%	-3.52%	-3.10%	-60.66%	3.62%
Augmented Payout Ratio	-3.57%	-2.84%	-2.73%	-2.86%	-3.08%	-3.40%	-3.89%	-3.60%	-3.16%	-61.74%	3.66%

Frequently Asked Questions About Diversified Healthcare Trust's Financials

When does Diversified Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Diversified Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Diversified Healthcare Trust's net income changed over the last 2 years?

Diversified Healthcare Trust's net income appears to be on an upward trend, with a most recent value of -$370.26 million in 2024, rising from -$15.77 million in 2022. The previous period was -$293.57 million in 2023. View Diversified Healthcare Trust's forecast to see where analysts expect Diversified Healthcare Trust to go next.

What is Diversified Healthcare Trust's operating income?

Diversified Healthcare Trust's total operating income in 2024 was -$125.83 million, based on the following breakdown:

Total Gross Profit: $1.50 billion
Total Operating Expenses: $1.62 billion

How has Diversified Healthcare Trust revenue changed over the last 2 years?

Over the last 2 years, Diversified Healthcare Trust's total revenue changed from $1.28 billion in 2022 to $1.50 billion in 2024, a change of 16.5%.

How much debt does Diversified Healthcare Trust have?

Diversified Healthcare Trust's total liabilities were at $3.18 billion at the end of 2024, a 2.2% increase from 2023, and a 5.5% decrease since 2022.

How much cash does Diversified Healthcare Trust have?

In the past 2 years, Diversified Healthcare Trust's cash and equivalents has ranged from $144.58 million in 2024 to $658.07 million in 2022, and is currently $144.58 million as of their latest financial filing in 2024.

How has Diversified Healthcare Trust's book value per share changed over the last 2 years?

Over the last 2 years, Diversified Healthcare Trust's book value per share changed from 11.01 in 2022 to 8.12 in 2024, a change of -26.2%.

Related Companies

This page (NASDAQ:DHC) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Diversified Healthcare Trust (DHC) Financials

Frequently Asked Questions About Diversified Healthcare Trust's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Diversified Healthcare Trust (DHC) Financials

Annual Income Statements for Diversified Healthcare Trust

Quarterly Income Statements for Diversified Healthcare Trust

Annual Cash Flow Statements for Diversified Healthcare Trust

Quarterly Cash Flow Statements for Diversified Healthcare Trust

Annual Balance Sheets for Diversified Healthcare Trust

Quarterly Balance Sheets for Diversified Healthcare Trust

Annual Metrics And Ratios for Diversified Healthcare Trust

Quarterly Metrics And Ratios for Diversified Healthcare Trust

Frequently Asked Questions About Diversified Healthcare Trust's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools